Well differentiated thyroid carcinoma: Current treatment

James Kenneth Byrd, Robert J. Yawn, Christina S.T. Wilhoit, Nicoleta D. Sora, Linda Meyers, Jyotika Fernandes, Terry Day

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Opinion statement: Well differentiated thyroid carcinoma (WDTC) is a relatively common malignancy accounting for an estimated 37,000 thousand cases in the United States in 2009 [1]. WDTC also has a generally high 5 year survival rate that correlates with age. Papillary thyroid carcinoma (PTC) greater than 1 cm is best managed by total thyroidectomy. Thyroid lobectomy and isthmusectomy may be adequate for unifocal PTC less than 1 cm in patients without negative prognostic factors. Central compartment and possible lateral neck dissections should be performed when nodal metastases are present in the respective nodal basins. Post-operatively, radioactive iodine ablation with 131I followed by thyroid stimulating hormone (TSH) suppression is indicated in certain patients to improve locoregional control and reduce recurrence.

Original languageEnglish (US)
Pages (from-to)47-57
Number of pages11
JournalCurrent Treatment Options in Oncology
Volume13
Issue number1
DOIs
StatePublished - Mar 1 2012

Fingerprint

Thyroid Neoplasms
Neck Dissection
Thyroidectomy
Thyrotropin
Iodine
Thyroid Gland
Survival Rate
Neoplasm Metastasis
Recurrence
Therapeutics
Neoplasms
Papillary Thyroid cancer

Keywords

  • Papillary thyroid cancer
  • Thyroglobulin
  • Thyroid cancer
  • Thyroidectomy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Byrd, J. K., Yawn, R. J., Wilhoit, C. S. T., Sora, N. D., Meyers, L., Fernandes, J., & Day, T. (2012). Well differentiated thyroid carcinoma: Current treatment. Current Treatment Options in Oncology, 13(1), 47-57. https://doi.org/10.1007/s11864-011-0173-1

Well differentiated thyroid carcinoma : Current treatment. / Byrd, James Kenneth; Yawn, Robert J.; Wilhoit, Christina S.T.; Sora, Nicoleta D.; Meyers, Linda; Fernandes, Jyotika; Day, Terry.

In: Current Treatment Options in Oncology, Vol. 13, No. 1, 01.03.2012, p. 47-57.

Research output: Contribution to journalArticle

Byrd, JK, Yawn, RJ, Wilhoit, CST, Sora, ND, Meyers, L, Fernandes, J & Day, T 2012, 'Well differentiated thyroid carcinoma: Current treatment', Current Treatment Options in Oncology, vol. 13, no. 1, pp. 47-57. https://doi.org/10.1007/s11864-011-0173-1
Byrd, James Kenneth ; Yawn, Robert J. ; Wilhoit, Christina S.T. ; Sora, Nicoleta D. ; Meyers, Linda ; Fernandes, Jyotika ; Day, Terry. / Well differentiated thyroid carcinoma : Current treatment. In: Current Treatment Options in Oncology. 2012 ; Vol. 13, No. 1. pp. 47-57.
@article{17eab33d6420467abf09232748a1672e,
title = "Well differentiated thyroid carcinoma: Current treatment",
abstract = "Opinion statement: Well differentiated thyroid carcinoma (WDTC) is a relatively common malignancy accounting for an estimated 37,000 thousand cases in the United States in 2009 [1]. WDTC also has a generally high 5 year survival rate that correlates with age. Papillary thyroid carcinoma (PTC) greater than 1 cm is best managed by total thyroidectomy. Thyroid lobectomy and isthmusectomy may be adequate for unifocal PTC less than 1 cm in patients without negative prognostic factors. Central compartment and possible lateral neck dissections should be performed when nodal metastases are present in the respective nodal basins. Post-operatively, radioactive iodine ablation with 131I followed by thyroid stimulating hormone (TSH) suppression is indicated in certain patients to improve locoregional control and reduce recurrence.",
keywords = "Papillary thyroid cancer, Thyroglobulin, Thyroid cancer, Thyroidectomy",
author = "Byrd, {James Kenneth} and Yawn, {Robert J.} and Wilhoit, {Christina S.T.} and Sora, {Nicoleta D.} and Linda Meyers and Jyotika Fernandes and Terry Day",
year = "2012",
month = "3",
day = "1",
doi = "10.1007/s11864-011-0173-1",
language = "English (US)",
volume = "13",
pages = "47--57",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Well differentiated thyroid carcinoma

T2 - Current treatment

AU - Byrd, James Kenneth

AU - Yawn, Robert J.

AU - Wilhoit, Christina S.T.

AU - Sora, Nicoleta D.

AU - Meyers, Linda

AU - Fernandes, Jyotika

AU - Day, Terry

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Opinion statement: Well differentiated thyroid carcinoma (WDTC) is a relatively common malignancy accounting for an estimated 37,000 thousand cases in the United States in 2009 [1]. WDTC also has a generally high 5 year survival rate that correlates with age. Papillary thyroid carcinoma (PTC) greater than 1 cm is best managed by total thyroidectomy. Thyroid lobectomy and isthmusectomy may be adequate for unifocal PTC less than 1 cm in patients without negative prognostic factors. Central compartment and possible lateral neck dissections should be performed when nodal metastases are present in the respective nodal basins. Post-operatively, radioactive iodine ablation with 131I followed by thyroid stimulating hormone (TSH) suppression is indicated in certain patients to improve locoregional control and reduce recurrence.

AB - Opinion statement: Well differentiated thyroid carcinoma (WDTC) is a relatively common malignancy accounting for an estimated 37,000 thousand cases in the United States in 2009 [1]. WDTC also has a generally high 5 year survival rate that correlates with age. Papillary thyroid carcinoma (PTC) greater than 1 cm is best managed by total thyroidectomy. Thyroid lobectomy and isthmusectomy may be adequate for unifocal PTC less than 1 cm in patients without negative prognostic factors. Central compartment and possible lateral neck dissections should be performed when nodal metastases are present in the respective nodal basins. Post-operatively, radioactive iodine ablation with 131I followed by thyroid stimulating hormone (TSH) suppression is indicated in certain patients to improve locoregional control and reduce recurrence.

KW - Papillary thyroid cancer

KW - Thyroglobulin

KW - Thyroid cancer

KW - Thyroidectomy

UR - http://www.scopus.com/inward/record.url?scp=84857659152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857659152&partnerID=8YFLogxK

U2 - 10.1007/s11864-011-0173-1

DO - 10.1007/s11864-011-0173-1

M3 - Article

C2 - 22234582

AN - SCOPUS:84857659152

VL - 13

SP - 47

EP - 57

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 1

ER -